These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
430 related articles for article (PubMed ID: 22228796)
1. Targeted near-infrared imaging of the erythropoietin receptor in human lung cancer xenografts. Doleschel D; Mundigl O; Wessner A; Gremse F; Bachmann J; Rodriguez A; Klingmüller U; Jarsch M; Kiessling F; Lederle W J Nucl Med; 2012 Feb; 53(2):304-11. PubMed ID: 22228796 [TBL] [Abstract][Full Text] [Related]
2. Erythropoietin improves the accumulation and therapeutic effects of carboplatin by enhancing tumor vascularization and perfusion. Doleschel D; Rix A; Arns S; Palmowski K; Gremse F; Merkle R; Salopiata F; Klingmüller U; Jarsch M; Kiessling F; Lederle W Theranostics; 2015; 5(8):905-18. PubMed ID: 26000061 [TBL] [Abstract][Full Text] [Related]
3. In-vivo detection of the erythropoietin receptor in tumours using positron emission tomography. Fuge F; Doleschel D; Rix A; Gremse F; Wessner A; Winz O; Mottaghy F; Lederle W; Kiessling F Eur Radiol; 2015 Feb; 25(2):472-9. PubMed ID: 25196361 [TBL] [Abstract][Full Text] [Related]
4. Activation and inhibition of the erythropoietin receptor by a membrane-anchored erythropoietin. Negre O; Fusil F; Henri A; Villette JM; Leboulch P; Beuzard Y; Payen E Exp Hematol; 2008 Apr; 36(4):412-23. PubMed ID: 18295963 [TBL] [Abstract][Full Text] [Related]
5. Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts. Ke S; Wen X; Gurfinkel M; Charnsangavej C; Wallace S; Sevick-Muraca EM; Li C Cancer Res; 2003 Nov; 63(22):7870-5. PubMed ID: 14633715 [TBL] [Abstract][Full Text] [Related]
6. No erythropoietin-induced growth is observed in non-small cell lung cancer cells. Frille A; Leithner K; Olschewski A; Olschewski H; Wohlkönig C; Hrzenjak A Int J Oncol; 2018 Feb; 52(2):518-526. PubMed ID: 29345289 [TBL] [Abstract][Full Text] [Related]
7. Erythropoietin receptor expression and correlation to tamoxifen response and prognosis in breast cancer. Larsson AM; Jirström K; Fredlund E; Nilsson S; Rydén L; Landberg G; Påhlman S Clin Cancer Res; 2009 Sep; 15(17):5552-9. PubMed ID: 19706814 [TBL] [Abstract][Full Text] [Related]
8. A "classical" homodimeric erythropoietin receptor is essential for the antiapoptotic effects of erythropoietin on differentiated neuroblastoma SH-SY5Y and pheochromocytoma PC-12 cells. Um M; Gross AW; Lodish HF Cell Signal; 2007 Mar; 19(3):634-45. PubMed ID: 17045782 [TBL] [Abstract][Full Text] [Related]
9. Expression of erythropoietin and its receptor in neuroblastomas. Sartelet H; Fabre M; Castaing M; Bosq J; Racu I; Lagonotte E; Scott V; Lecluse Y; Barette S; Michiels S; Vassal G Cancer; 2007 Sep; 110(5):1096-106. PubMed ID: 17647284 [TBL] [Abstract][Full Text] [Related]
10. A Cy5.5-labeled phage-displayed peptide probe for near-infrared fluorescence imaging of tumor vasculature in living mice. Chen K; Yap LP; Park R; Hui X; Wu K; Fan D; Chen X; Conti PS Amino Acids; 2012 Apr; 42(4):1329-37. PubMed ID: 21212998 [TBL] [Abstract][Full Text] [Related]
11. Induction of signalling in non-erythroid cells by pharmacological levels of erythropoietin. Dunlop EA; Percy MJ; Boland MP; Maxwell AP; Lappin TR Neurodegener Dis; 2006; 3(1-2):94-100. PubMed ID: 16909043 [TBL] [Abstract][Full Text] [Related]
12. Post-secretion neutralization of transgene-derived effect: soluble erythropoietin receptor/IgG1Fc expressed in liver neutralizes erythropoietin produced in muscle. Maruyama H; Higuchi M; Higuchi N; Kameda S; Saito M; Sugawa M; Matsuzaki J; Neichi T; Yokoyama S; Miyazaki Y; Miyazaki J; Gejyo F J Gene Med; 2004 Feb; 6(2):228-37. PubMed ID: 14978776 [TBL] [Abstract][Full Text] [Related]
13. Erythropoietin and erythropoietin receptor expression in vestibular schwannoma: potential role in tumor progression. Diensthuber M; Ilner T; Rodt T; Samii M; Brandis A; Lenarz T; Stöver T Otol Neurotol; 2007 Jun; 28(4):559-65. PubMed ID: 17429338 [TBL] [Abstract][Full Text] [Related]
14. The role of erythropoietin and erythropoietin receptor in malignant laryngeal tumors. Vukelic J; Dobrila-Dintinjana R; Jonjic N; Dekanic A; Ilijic V Med Hypotheses; 2013 Dec; 81(6):1155-8. PubMed ID: 24134826 [TBL] [Abstract][Full Text] [Related]
15. Hypertension induced by erythropoietin has a correlation with truncated erythropoietin receptor mRNA in endothelial progenitor cells of hemodialysis patients. Ioka T; Tsuruoka S; Ito C; Iwaguro H; Asahara T; Fujimura A; Kusano E Clin Pharmacol Ther; 2009 Aug; 86(2):154-9. PubMed ID: 19458615 [TBL] [Abstract][Full Text] [Related]
16. Erythropoietin accelerates tumor growth through increase of erythropoietin receptor (EpoR) as well as by the stimulation of angiogenesis in DLD-1 and Ht-29 xenografts. Tankiewicz-Kwedlo A; Hermanowicz J; Surażynski A; Rożkiewicz D; Pryczynicz A; Domaniewski T; Pawlak K; Kemona A; Pawlak D Mol Cell Biochem; 2016 Oct; 421(1-2):1-18. PubMed ID: 27543111 [TBL] [Abstract][Full Text] [Related]
17. Expression pattern of erythropoietin and erythropoietin receptor in experimental model of retinal detachment. Xie Z; Wu X; Qiu Q; Gong Y; Song Y; Gu Q; Li C Curr Eye Res; 2007 Sep; 32(9):757-64. PubMed ID: 17882708 [TBL] [Abstract][Full Text] [Related]
18. Recombinant human erythropoietin in combination with chemotherapy increases breast cancer metastasis in preclinical mouse models. Hedley BD; Chu JE; Ormond DG; Beausoleil MS; Boasie A; Allan AL; Xenocostas A Clin Cancer Res; 2011 Oct; 17(19):6151-62. PubMed ID: 21856770 [TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of erythropoietin expression in human endometrial carcinoma. Acs G; Xu X; Chu C; Acs P; Verma A Cancer; 2004 Jun; 100(11):2376-86. PubMed ID: 15160341 [TBL] [Abstract][Full Text] [Related]
20. [Expression of erythropoietin and erythropoietin receptor in non-small cell lung cancer and its correlation with microvessel density]. Han ZG; Yu TT; Shan L Zhonghua Zhong Liu Za Zhi; 2012 Aug; 34(8):605-8. PubMed ID: 23158995 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]